CareAdvantage Cal MediConnect Plan (Medicare-Medicaid Plan) 2020
CareAdvantage covers brand and generic medications that are:
- Prescribed by your doctor
- Taken by yourself at home
- Given to you at a doctor's office, hospital or skilled nursing facility
- Given to you in the form of injections related to dialysis and chemotherapy
In general, CareAdvantage only covers prescriptions that are filled by network pharmacies. However, there are certain circumstances under which CareAdvantage will reimburse you for prescriptions filled by out-of-network pharmacies.
Find a covered drug
Coverage Limitations and Exceptions
Prior Authorization Criteria (PA)
These drugs are in the CareAdvantage Formulary but need to be pre-approved before you fill a prescription. This also includes the criteria for approval of each drug.
Quantity Limits (QL)
These drugs are covered but have a set limit on the amount of pills per prescription and the number of times they can be refilled without further authorization.
Step Therapy Criteria (ST)
Some drugs are covered only after you have a tried a recommended drug, but it did not work. When there are two drugs for your condition, CareAdvantage may require you to try one drug first before covering the other drug.
Drugs Not Covered
By law, there are categories of drugs that Medicare Part B and Part D, and Medi-Cal, cannot cover. You can still get drugs that are not covered, but CareAdvantage will not pay for them. You must pay for the full cost of drugs not covered.
Download the Formulary
CareAdvantage Cal MediConnect Plan (Medicare-Medicaid Plan) is a health plan that contracts with both Medicare and Medi-Cal to provide benefits of both programs to enrollees. Limitations and restrictions may apply. For more information, call the CareAdvantage Unit or read the CareAdvantage Member Handbook.
Benefits and co-pays may change on January 1 of each year.
If you speak other languages other than English, language assistance services, free of charge, are available to you. Call 1-866-880-0606 (TTY: 1-800-735-2929). (Download this statement in multiple languages.)
Page updated September 24, 2019